Linalool is a monoterpene compound reported to be a major component of esse
ntial oils of several aromatic species. Several linalool-producing species
are used in traditional medical systems for sedative purposes, including th
e interruption and prevention of seizures. Previous studies in mice reveale
d that linalool modulates glutamatergic (competitive antagonism Of L-[H-3]g
lutamate binding, delayed intraperitoneal NMDA-induced convulsions and bloc
kade of intracerebroventricular Quin-induced convulsions) and GABAergie tra
nsmission (protection against pentylenetetrazol and picrotoxin-induced conv
ulsions). To further clarify the anticonvulsive mechanisms of linalool, we
studied the effects of linalool on binding of [H-3]MK801 (NMDA antagonist)
and [H-3]muscimol (GABAA agonist) to mouse cortical membranes. Linalool sho
wed a dose dependent non-competitive inhibition of [H-3]MK801 binding (IC50
= 2.97 mM) but no effect on [H-3]muscimol binding. The data suggest that t
he anticonvulsant mode of action of linalool includes a direct interaction
with the NMDA receptor complex. The data do not, however, support a direct
interaction of linalool with GABAA receptors, although changes in GABA-medi
ated neuronal inhibition or effects on GABA release and uptake cannot be ru
led out.